COO - CooperCompanies Total Debt to Capital

CooperVision (COO) - corporate logo

The Cooper Companies (COO) minimizes personnel errors by implementing production robotization for lenses and instruments via AI control. The debt-to-equity ratio confirms the strategy's stability, with the metric fixed at 0.32. Automated conveyors with restricted human access guarantee product sterility. Raw material diversification and a well-structured global distribution network for finished medical equipment ensure supply stability.

COO: coopercos.com Total Debt to Equity Ratio 07/04/2022 - 10/30/2026
Finished products of The Cooper Companies

Total debt-to-equity measures the proportion of borrowed funds relative to equity, determining the degree of financial leverage. An increase in this ratio signals heightened insolvency risks and dependence on creditors. By analyzing this financial stability ratio chart, an investor assesses the quality of the balance sheet. For The Cooper Companies (COO), this metric reflects the cost of expansion through the acquisition of medtech developers. Strategic alliances in ophthalmology require a precise balance between borrowings and liquidity.

Competitor analysis

Debt to Equity Boston Scientific Corporation|Edwards - Aggregate Debt to Equity|Total Debt to Capital RMD|PODD - Debt to Capital|Total Debt to Capital ZBH (Zimmer Biomet Corp)|ALGN - Total Debt to Equity Ratio|Globus Medical - Total Debt to Capital|Total Debt to Capital Coefficient transmedics.com TMDX|ATEC: Total Debt to Capital|Artivion Corp (AORT) - Total Debt to Capital|Debt to Equity Enovis Corporation|Debt to Equity IART|Total Debt to Capital ESTA|Total Debt to Capital Coefficient Beta Bionics, Inc.|Iradimed - Total Debt to Equity Ratio|EMBC (Embecta Health) - Aggregate Debt to Equity|Tandem Diabetes Care - Total Debt to Capital|Debt to Capital axogeninc.com|SIBN: Total Debt to Capital|Debt to Equity Ratio OFIX|Total Debt to Equity Ratio BVS|KIDS: All Debt to Shareholders' Equity Ratio|Debt to Equity Treace Medical Concepts (TMCI)|Total Debt to Equity Ratio blade.com SRTA|Total Debt to Capital CARL (Carlsmed)|RxSight Inc (RXST) - Debt to Capital|ClearPoint - Total Debt to Capital|STXS (Stereotaxis Corporation) - Debt to Equity Ratio|STIM: Total Debt to Capital|SGHT - Total Debt to Capital Coefficient|OBIO (Orchestra BioMed, Inc.) - Total Debt to Capital|Total Debt to Equity Ratio Anika (ANIK)|Total Debt to Capital NSPR|Total Debt to Capital zhjmedical.com (ZJYL)|Debt to Equity Vivani Medical VANI|Xtant Medical Holdings, Inc. - Debt to Equity|NMTC: Total Debt to Equity Ratio|All Debt to Shareholders' Equity Ratio MODD (Modular Medical)|MYO: Total Debt to Capital|Debt to Capital Envoy Medical Inc (COCH)|Debt to Equity Vivos Therapeutics|NVNO - Debt to Capital Ratio|Total Debt to Equity Ratio SINT (Sintx Technologies)|Total Debt to Capital Tenon Medical Inc. (TNON)|Total Debt to Capital LFWD (ReWalk Robotics Ltd)|Total Debt to Capital Coefficient Autonomix Medical Inc. (AMIX)|IVF - Debt to Equity|Aggregate Debt to Equity BBLG|Axonics (AXNX) - Debt to Equity|Total Debt to Equity Ratio BIOLASE Inc.|DYNT (Dynatronics Corp) - Total Debt to Capital|Debt to Capital Paragon 28 Corp FNA|Debt to Equity INVO Bioscience, Inc. (INVO)